Local Therapy for Oligoprogressive Disease: A Systematic Review of Prospective Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Local Therapy for Oligoprogressive Disease: A Systematic Review of Prospective Trials

Published:2022-11 Issue:4 Volume:114 Page:676-683
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kim Hans,Venkatesulu Bhanu P.,McMillan Matthew T.,Verma Vivek,Lin Steven H.,Chang Joe Y.,Welsh James W.

Funder

Elekta

MedImmune

AstraZeneca

Varian Medical Systems

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference26 articles.

1. Oligometastases;Hellman;J Clin Oncol,1995

2. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET phase II randomized trial;Palma;J Clin Oncol,2020

3. Wu Y, Verma V, Liang F, et al. Local consolidative therapy versus systemic therapy alone for metastatic non-small lung cancer: A systematic review and meta-analysis [e-pub ahead of print]. Int J Radiat Oncol Biol Phys. Available at: https://doi.org/10.1016/j.ijrobp.2022.02.023. Accessed February 20, 2022.

4. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study;Gomez;J Clin Oncol,2019

5. Wang XS, Bai YF, Verma V, et al. Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer [e-pub ahead of print]. J Natl Cancer Inst. Available at: https://doi.org/10.1093/jnci/djac065. Accessed February 20, 2022

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic ablative radiotherapy for oligoprogressive solid tumours: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-11

2. Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial;International Journal of Radiation Oncology*Biology*Physics;2024-08

3. Systematic review of the efficacy of stereotactic ablative radiotherapy for oligoprogressive disease in metastatic cancer;Radiotherapy and Oncology;2024-07

4. Navigating Breast Cancer Oligometastasis and Oligoprogression: Current Landscape and Future Directions;Current Oncology Reports;2024-04-23

5. Additional local therapy before disease progression for EGFR-mutated advanced lung cancer: a systematic review and meta-analysis;Translational Lung Cancer Research;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3